CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02742727

Recruitment Status : Unknown

Verified December 2016 by PersonGen BioTherapeutics (Suzhou) Co., Ltd..
Recruitment status was: Recruiting

First Posted : April 19, 2016

Last Update Posted : December 6, 2016

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

The First People's Hospital of Hefei

Hefei Binhu Hospital

Information provided by (Responsible Party):

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	March 2017
Estimated Study Completion Date :	March 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Del Zotto G, Marcenaro E, Vacca P, Sivori S, Pende D, Della Chiesa M, Moretta F, Ingegnere T, Mingari MC, Moretta A, Moretta L. Markers and function of human NK cells in normal and pathological conditions. Cytometry B Clin Cytom. 2017 Mar;92(2):100-114. doi: 10.1002/cyto.b.21508. Epub 2017 Feb 12.

To Top